Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome
APPROVED_FOR_MARKETING
Status
Conditions
- Congenital Myasthenic Syndrome
- Lambert-Eaton Myasthenic Syndrome
- Nystagmus, Acquired
Interventions
- DRUG: Amifampridine Phosphate
Sponsor
Catalyst Pharmaceuticals, Inc.